Denali Therapeutics Inc. - COM (DNLI)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / COM
Number of holders
203
Total Shares
85.2M
Shares change
+634K
Total reported value, excl. options
$3.8B
Value change
+$17.1M
Put/Call ratio
3.59
Number of buys
101
Number of sells
-83
Price
$44.60
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.